Gut microbiota severely hampers the efficacy of NAD-lowering therapy in leukemiaOussama ElMokh, Michel A. Duchosal, Héctor Gallart‐Ayala et al.|Cell Death and Disease|2022Cited by 16
Synthesis and structure-activity relationship of new nicotinamide phosphoribosyltransferase inhibitors with antitumor activity on solid and haematological cancerSimone Fratta, Inmaculada Robina, Alessio Nencioni et al.|European Journal of Medicinal Chemistry|2023Cited by 8
Anticancer Activities of Novel Nicotinamide Phosphoribosyltransferase Inhibitors in Hematological MalignanciesPaulina Biniecka, Aimable Nahimana, Saki Matsumoto et al.|Molecules|2023Cited by 8